04/05/2024
3:34 PM | Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/05/2024
9:13 AM | Flores Francisco (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/05/2024
9:14 AM | Mokhtar Firdauz (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/27/2024
8:45 AM | Choong Choon Hau (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
11:19 AM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
3:59 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
4:13 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
12/28/2023
3:30 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:30 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
3:05 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
3:15 PM | Titan Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/26/2023
3:23 PM | Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:25 PM | Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:29 PM | Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:31 PM | McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2023
3:33 PM | NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2023
4:26 PM | Titan Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/23/2023
2:07 PM | Chiam Brynner (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
4:08 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:30 PM | Sire Group Ltd. (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D | |
10/04/2023
3:40 PM | Shen Seow Gim (Reporting)
Sire Group Ltd. (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/19/2023
3:41 PM | Titan Pharmaceuticals (Filer)
| Form 8-K/A | |
09/18/2023
3:45 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
4:30 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
3:28 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:08 PM | Titan Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
7:06 PM | Greenberg Eric Howard (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
6:42 PM | McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4/A | |
07/31/2023
6:44 PM | Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4/A | |
07/31/2023
6:45 PM | NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4/A | |
07/31/2023
6:38 PM | Ben-Tzvi Avraham (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
6:39 PM | Lazar David E. (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:42 PM | NATAN DAVID (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:43 PM | McMurdo Matthew Charles (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:45 PM | Beebe Katherine (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:47 PM | Chasey Peter Louis (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
8:57 PM | Choong Choon Hau (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D | |
07/20/2023
8:57 PM | Choong Choon Hau (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/07/2023
9:28 AM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:15 PM | Titan Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
4:28 PM | Titan Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
The only accurate crypto trading system I know … (Ad) Juan Villaverde is no ordinary crypto trader.
His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin …
It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money. Here's what our expert says you should buy before April 14. |
06/23/2023
3:05 PM | Activist Investing LLC (Filed by)
Titan Pharmaceuticals (Subject)
| Form SC 13D/A | |
06/23/2023
3:07 PM | Activist Investing LLC (Reporting)
Lazar David E. (Reporting)
Titan Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2023
9:17 AM | Titan Pharmaceuticals (Filer)
| Form ARS | |
05/19/2023
8:30 AM | Titan Pharmaceuticals (Filer)
| Form DEFA14A | |
05/19/2023
8:22 AM | Titan Pharmaceuticals (Filer)
| Form DEF 14A | |
